Overview
Disorder of phospholipids, sphingolipids, and fatty acids biosynthesis with skeletal muscle predominant involvement is an extremely rare group of inherited metabolic conditions. In these disorders, the body has trouble making certain types of fats (called lipids) that are essential for normal cell function. Specifically, the body struggles to produce phospholipids, sphingolipids, or fatty acids — all of which are critical building blocks for cell membranes and play important roles in how cells communicate and function. Because skeletal muscles are particularly affected, the main symptoms tend to involve muscle weakness, muscle wasting, exercise intolerance, and difficulty with physical activities. Patients may notice progressive difficulty walking, climbing stairs, or performing everyday tasks that require muscle strength. The severity can vary depending on the specific genetic cause. Because these conditions are so rare, the treatment landscape is currently limited and mostly focused on managing symptoms rather than curing the underlying problem. Physical therapy, occupational therapy, and supportive care are the mainstays of management. Research is ongoing to better understand these conditions and develop targeted therapies.
Key symptoms:
Muscle weaknessMuscle wastingExercise intoleranceDifficulty walking or climbing stairsFatigue during physical activityProgressive loss of muscle strengthMuscle pain or crampingDifficulty with fine motor tasksReduced muscle toneDelayed motor milestones in children
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for Disorder of phospholipids, sphingolipids and fatty acids biosynthesis with skeletal muscle predominant involvement.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Disorder of phospholipids, sphingolipids and fatty acids biosynthesis with skeletal muscle predominant involvement at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Disorder of phospholipids, sphingolipids and fatty acids biosynthesis with skeletal muscle predominant involvement.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Financial Resources
1 resourcesKETALAR
Par Health USA, LLC
KETALAR — Contact Par Health USA, LLC
Travel Grants
No travel grants are currently matched to Disorder of phospholipids, sphingolipids and fatty acids biosynthesis with skeletal muscle predominant involvement.
Community
No community posts yet. Be the first to share your experience with Disorder of phospholipids, sphingolipids and fatty acids biosynthesis with skeletal muscle predominant involvement.
Start the conversation →Latest news about Disorder of phospholipids, sphingolipids and fatty acids biosynthesis with skeletal muscle predominant involvement
No recent news articles for Disorder of phospholipids, sphingolipids and fatty acids biosynthesis with skeletal muscle predominant involvement.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What specific genetic cause has been identified for my condition, and what does that mean for my prognosis?,Are there any clinical trials or experimental treatments I should consider?,What type of physical therapy program would be most beneficial for me?,Are there any dietary changes or supplements that might help?,How often should I have follow-up appointments and what tests should be monitored regularly?,Should my family members be tested for this condition?,What signs or symptoms should prompt me to seek emergency care?
Common questions about Disorder of phospholipids, sphingolipids and fatty acids biosynthesis with skeletal muscle predominant involvement
What is Disorder of phospholipids, sphingolipids and fatty acids biosynthesis with skeletal muscle predominant involvement?
Disorder of phospholipids, sphingolipids, and fatty acids biosynthesis with skeletal muscle predominant involvement is an extremely rare group of inherited metabolic conditions. In these disorders, the body has trouble making certain types of fats (called lipids) that are essential for normal cell function. Specifically, the body struggles to produce phospholipids, sphingolipids, or fatty acids — all of which are critical building blocks for cell membranes and play important roles in how cells communicate and function. Because skeletal muscles are particularly affected, the main symptoms tend
How is Disorder of phospholipids, sphingolipids and fatty acids biosynthesis with skeletal muscle predominant involvement inherited?
Disorder of phospholipids, sphingolipids and fatty acids biosynthesis with skeletal muscle predominant involvement follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
What treatment and support options exist for Disorder of phospholipids, sphingolipids and fatty acids biosynthesis with skeletal muscle predominant involvement?
1 patient support program are currently tracked on UniteRare for Disorder of phospholipids, sphingolipids and fatty acids biosynthesis with skeletal muscle predominant involvement. See the treatments and support programs sections for copay assistance, eligibility, and contact details.